ATE321762T1 - Verfahren zur synthese von carbapenem-antibiotika - Google Patents

Verfahren zur synthese von carbapenem-antibiotika

Info

Publication number
ATE321762T1
ATE321762T1 AT99908540T AT99908540T ATE321762T1 AT E321762 T1 ATE321762 T1 AT E321762T1 AT 99908540 T AT99908540 T AT 99908540T AT 99908540 T AT99908540 T AT 99908540T AT E321762 T1 ATE321762 T1 AT E321762T1
Authority
AT
Austria
Prior art keywords
formula
synthesis
compound
heteroaryl
aryl
Prior art date
Application number
AT99908540T
Other languages
English (en)
Inventor
John M Williams
Karel M J Brands
Renato Skerlj
Peter Houghton
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810888.9A external-priority patent/GB9810888D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE321762T1 publication Critical patent/ATE321762T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99908540T 1998-03-02 1999-02-26 Verfahren zur synthese von carbapenem-antibiotika ATE321762T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7682998P 1998-03-02 1998-03-02
GBGB9810888.9A GB9810888D0 (en) 1998-05-20 1998-05-20 Process for synthesizing carbapenem antibiotics

Publications (1)

Publication Number Publication Date
ATE321762T1 true ATE321762T1 (de) 2006-04-15

Family

ID=26313717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99908540T ATE321762T1 (de) 1998-03-02 1999-02-26 Verfahren zur synthese von carbapenem-antibiotika

Country Status (8)

Country Link
EP (1) EP1060180B1 (de)
JP (1) JP3953274B2 (de)
AT (1) ATE321762T1 (de)
AU (1) AU749234B2 (de)
CA (1) CA2322658C (de)
DE (1) DE69930616T2 (de)
ES (1) ES2260900T3 (de)
WO (1) WO1999045010A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
AU2001267011B2 (en) 2000-06-21 2006-02-02 Cubist Pharmaceuticals, Inc. Compositions and methods to improve the oral absorption of antimicrobial agents
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
EP1426376A4 (de) * 2001-08-13 2004-12-22 Eisai Co Ltd Verfahren zur herstellung von carbapenem-antibiotika
KR100628676B1 (ko) 2001-09-26 2006-09-27 머크 앤드 캄파니 인코포레이티드 카바페넴 화합물의 제조방법
WO2003026572A2 (en) * 2001-09-26 2003-04-03 Merck & Co., Inc. Crystalline forms of ertapenem sodium
JP4481829B2 (ja) * 2002-11-13 2010-06-16 株式会社カネカ 経口投与用カルバペネム化合物の新規合成中間体及びその製造方法
NZ580951A (en) 2005-04-29 2011-06-30 Cubist Pharm Inc Therapeutic compositions
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)-1-(4-硝基苄氧羰基)-2-[(3-烯丙氧羰基)-苯基氨基甲酰基]-吡咯烷-4-基硫醇的制备方法
WO2009150630A2 (en) 2008-06-11 2009-12-17 Ranbaxy Laboratories Limited Process for preparing a carbapenem antibiotic composition
CN102558182B (zh) * 2010-12-31 2015-02-11 石药集团中奇制药技术(石家庄)有限公司 一种厄他培南钠晶型及其制备方法
CN114105988B (zh) * 2022-01-24 2022-04-29 深圳市海滨制药有限公司 一种厄他培南钠的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
TW264475B (de) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds

Also Published As

Publication number Publication date
AU749234B2 (en) 2002-06-20
AU2794799A (en) 1999-09-20
WO1999045010A1 (en) 1999-09-10
EP1060180B1 (de) 2006-03-29
JP3953274B2 (ja) 2007-08-08
ES2260900T3 (es) 2006-11-01
EP1060180A4 (de) 2004-03-10
JP2002505331A (ja) 2002-02-19
CA2322658C (en) 2005-04-12
CA2322658A1 (en) 1999-09-10
DE69930616D1 (de) 2006-05-18
DE69930616T2 (de) 2006-11-23
EP1060180A1 (de) 2000-12-20

Similar Documents

Publication Publication Date Title
DE69930616D1 (de) Verfahren zur synthese von carbapenem-antibiotika
AP1709A (en) Ethanolate of azithromycin, process for manufacure, and pharmaceutical compositions thereof.
EA200201264A1 (ru) 5-хлор-3(4-метансульфонилфенил)-6'-метил-[2,3']бипиридинил в чистой кристаллической форме и способ синтеза
ES2013403A6 (es) Procedimiento para preparar derivados de cefem.
FI101965B (fi) Klavulaanihapon 2-amino-2,4,4-trimetyylipentaanisuolan käyttö klavulaa nihapon alkali- tai maa-alkalimetallisuolojen valmistuksessa
KR100200242B1 (ko) 클라불란산염의 제조 방법
EP0991651A4 (de) Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
EP1460065A4 (de) Verfahren zur herstellung von cyclischen diaminverbindungen bzw. deren salzen
YU47191B (sh) Postupak za dobijanje benzazepin sulfonamida i njegove soli
US4089963A (en) Esters of amidinopenicillanic acids, pharmaceutical preparations and method for treating infectious diseases
EP0220435B1 (de) Verfahren zur Herstellung optisch aktiver Halbester
US4325886A (en) Optical resolution of acylthiopropionic acid
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
NZ508179A (en) Process for preparing crystalline salts of amoxycillin
SK64098A3 (en) Production of a salt of clavulanic acid
CA2030342A1 (en) Process for producing 2-carbon-substituted carbapenem derivatives
ATE112257T1 (de) Phenylglycinderivate.
CA2531578A1 (en) A new process for preparation of imipenem
GB1464431A (en) Indolobenzazepine derivatives and a process for the manufacture thereof
KR930021632A (ko) 벤조[b]티오펜-5-일 유도체 및 이의 제조방법
RU95119619A (ru) Способ получения 2-(фурил-2)-1,3-диоксанов
GB2047243A (en) Preparing derivatives of 6 - amidino - penicillanic acid
IE58551B1 (en) Method for preparing 6beta-halopenicillanic acids and salt thereof
EP1346979A1 (de) Verfahren zur herstellung von n-geschützten aminoalkoholen und n-geschützen aminoepoxiden
CA2319138A1 (en) Method for producing s-alkyl(aryl)-substituted imidazol derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties